提高吸收率、提高功效、提高活性成分含量
提高吸收率、提高功效、提高活性成分含量
标准可控、剂型适配、成本突破
全球独家发明专利，灵活定制，满足各类需求
溶解性更好，粒径分布更均匀
原料选材更安全
新品研发放心用
相比传统剂型产品，吸收率更好，生物利用度高
技术成熟可定制
| Patents Name | Patents No. |
| Liposomes with Ginsenoside as Membrane and Preparations and Use Thereof | CN201610693884.2,WO2017028811A1,US20170172920,EP16836675.5, CA2994032,AU2016309847(licensed),JP2018-528372 |
| Novel Liposomes with Ginsenoside Derivative as Membrane Material and Preparations Thereof | ZL201811447245.3 |
| A Novel Blank Liposome with Ginsenoside Rg3 or its Analog as Membrane Materials and Preparations and Uses Thereof | ZL201811447243.4, US20200369714 |
| A blank mixed micelle and preparations and uses thereof | ZL201711432287.5 |
| A Novel Blank Liposome with Glycyrrhizic acid or its Analog as Membrane Materials and Preparations and Uses Thereof | ZL201510795026.4 |
| A Novel Paclitaxel Liposome and Preparations | ZL202010934453.7,ZL202010904848.2,ZL202011229476.4 |
| A Novel Docetaxel Liposome and Preparations | ZL202010934433.X,ZL202010904850.X,ZL202011534465.7 |
| Novel Ginsenoside and Cabazitaxel Liposomes and Preparations | CN202110485574.2 |
| Novel Ginsenoside and Adriamycin/Epirubicin Liposomes and Preparations | CN202110671942.2,ZL202110652144.5 |
| Novel Ginsenoside and Irinotecan Liposomes and Preparations | CN202110705785.2 |
| Novel Ginsenoside and Vincristine Liposomes and Preparations | ZL202110642769.3 |
| Novel Ginsenoside and Homoharringtonine Liposomes and Preparations | CN202110350360.4 |
| Novel Ginsenoside and Mitoxantrone Liposomes and Preparations | CN202110678285.4 |
品控严 质量稳 交付快
